Cerebral palsy laboratory findings

Jump to navigation Jump to search

Cerebral palsy Microchapters


Patient Information


Historical Perspective




Differentiating Cerebral Palsy from other Diseases

Epidemiology and Demographics

Risk Factors


Natural History, Complications and Prognosis


Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings



Echocardiography and Ultrasound

CT scan


Other Imaging Findings

Other Diagnostic Studies


Medical Therapy


Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cerebral palsy laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides


American Roentgen Ray Society Images of Cerebral palsy laboratory findings

All Images
Echo & Ultrasound
CT Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cerebral palsy laboratory findings

CDC on Cerebral palsy laboratory findings

Cerebral palsy laboratory findings in the news

Blogs on Cerebral palsy laboratory findings

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Cerebral palsy laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Iqra Qamar M.D.[2]


There are no diagnostic laboratory findings associated with cerebral palsy. The American Academy of Neurology (AAN) recommends lab studies if there is no specific structural abnormality present-, the presence of atypical features in history or physical examination and cerebral palsy associated with brain malformation. Following labs may help to rule out other diseases and may include thyroid function tests, lactate and pyruvate levels, organic and amino acids, ammonia levels and chromosomal analysis.

Laboratory Findings


  1. Ashwal S, Russman BS, Blasco PA, Miller G, Sandler A, Shevell M, Stevenson R (2004). "Practice parameter: diagnostic assessment of the child with cerebral palsy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society". Neurology. 62 (6): 851–63. PMID 15037681.
  2. Pons R, Collins A, Rotstein M, Engelstad K, De Vivo DC (2010). "The spectrum of movement disorders in Glut-1 deficiency". Mov. Disord. 25 (3): 275–81. doi:10.1002/mds.22808. PMID 20063428.
  3. Senbil N, Yüksel D, Yilmaz D, Gürer YK (2007). "Prothrombotic risk factors in children with hemiplegic cerebral palsy". Pediatr Int. 49 (5): 600–2. doi:10.1111/j.1442-200X.2007.02424.x. PMID 17875083.
  4. Simchen MJ, Goldstein G, Lubetsky A, Strauss T, Schiff E, Kenet G (2009). "Factor v Leiden and antiphospholipid antibodies in either mothers or infants increase the risk for perinatal arterial ischemic ]journal=Stroke". 40 (1): 65–70. doi:10.1161/STROKEAHA.108.527283. PMID 18927445.

Template:WH Template:WS